After ODAC: The State Of Accelerated Approval At The US FDA

US FDA’s Accelerated Approval process has always been a deceptively simple idea. After a three-day public review of ‘dangling’ applications, the underlying complexity remains.

Will Pazdur be able to tell his fellow oncologists that the state of accelerated approval is strong?

More from US FDA Performance Tracker

More from Regulatory Trackers